| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.35 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |